Experience with intravesical bacillus Calmette-Guèrin therapy of superficial bladder tumors. Academic Article uri icon

Overview

abstract

  • Between March, 1978, and July, 1981, 86 patients with polychronotopic superficial papillary bladder tumors and concurrent carcinoma in situ were randomized to receive either transurethral resection alone (43) or TUR plus BCG (43). The results indicate that BCG is not only active in preventing recurrences of new tumors but also effective for the diffuse, flat carcinoma in situ.

publication date

  • February 1, 1985

Research

keywords

  • BCG Vaccine
  • Carcinoma in Situ
  • Carcinoma, Papillary
  • Neoplasm Recurrence, Local
  • Urinary Bladder Neoplasms

Identity

Scopus Document Identifier

  • 0022223561

PubMed ID

  • 3881870

Additional Document Info

volume

  • 25

issue

  • 2